Which are the symptoms of Pigmented villonodular synovitis?

TL;DR: Pigmented villonodular synovitis (PVNS), now more commonly referred to as tenosynovial giant cell tumor (TGCT), typically presents as chronic joint pain, swelling, and restricted range of motion, most frequently in the knee. These symptoms often develop gradually over months or years, leading to mechanical locking or "giving way" of the affected joint due to the proliferation of the synovial lining.

What are the primary symptoms of Pigmented villonodular synovitis?

The clinical presentation of Pigmented villonodular synovitis is characterized by the progressive growth of abnormal tissue within the joint lining (synovium). Patients most commonly report a combination of persistent joint pain and recurrent swelling. Unlike acute injuries, the pain associated with Pigmented villonodular synovitis is often dull and aching, but it can become sharp during movement. Because the disease involves the overgrowth of synovial cells, the joint may feel "full" or stiff, particularly in the morning or after periods of inactivity.

What are the early warning signs of Pigmented villonodular synovitis?

Early symptoms of Pigmented villonodular synovitis are frequently non-specific, which can lead to delays in diagnosis. Patients and families should watch for the following clinical indicators:

• Unexplained, recurrent swelling of a single joint (monoarthritis), most commonly the knee, hip, or ankle.


• A sensation of "locking" or "catching" within the joint, caused by the physical mass of the tumor interfering with joint mechanics.


• A gradual decrease in the range of motion that does not resolve with rest or anti-inflammatory medication.


• Episodes of "giving way" or instability, which may suggest that the synovial mass is disrupting joint stability.

How does the severity of Pigmented villonodular synovitis vary?

The severity of Pigmented villonodular synovitis varies significantly based on whether the condition is localized or diffuse. In localized forms, the tumor is restricted to a small area, often resulting in fewer symptoms and a better prognosis. In the diffuse form of Pigmented villonodular synovitis, the entire synovium is affected, leading to more extensive joint destruction, bone erosions, and chronic pain. The impact on quality of life is profound in diffuse cases, as the persistent inflammation and physical mass can lead to secondary osteoarthritis and severe functional impairment, making daily activities like walking or climbing stairs difficult.

When should I seek immediate medical attention for joint symptoms?

While Pigmented villonodular synovitis is generally a slow-growing condition, you should seek prompt evaluation by an orthopedic specialist if you experience sudden, severe joint locking that prevents movement, intense localized heat or redness that may mimic an infection, or a rapid, dramatic increase in joint volume. Any patient with chronic, unexplained monoarthritis that fails to respond to standard conservative management for more than 4-6 weeks should be evaluated for potential synovial pathology.

How does Pigmented villonodular synovitis progress over time?

Without treatment, Pigmented villonodular synovitis tends to progress slowly. The recurring inflammation leads to the deposition of hemosiderin (an iron-storage complex) within the joint, which gives the tissue its characteristic pigmented appearance. Over time, this chronic inflammatory state causes the erosion of adjacent bone and cartilage, potentially leading to irreversible joint damage. Early intervention is crucial to preserve joint function and prevent long-term structural changes.

Next steps

• Consult an orthopedic surgeon or a musculoskeletal oncologist for an MRI, which is the gold standard for visualizing the extent of Pigmented villonodular synovitis.


• Connect with the 31 other community members on DiseaseMaps.org to share experiences and coping strategies.


• Inquire about systemic treatment options, such as CSF1R inhibitors, if surgery is not a viable or sufficient option for your specific case.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Pigmented villonodular synovitis (ORPHA:3305)


• NIH GARD (Genetic and Rare Diseases Information Center): Tenosynovial giant cell tumor


• OMIM (Online Mendelian Inheritance in Man): Synovitis, pigmented villonodular


• American Academy of Orthopaedic Surgeons (AAOS): Tenosynovial Giant Cell Tumors